Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.63
0.03 (5.00%)
At close: Aug 15, 2025, 3:47 PM
0.61
-2.38%
After-hours: Aug 15, 2025, 03:47 PM EDT
Brainstorm Cell Therapeutics Fail-to-Deliver
Total FTD Shares
31.27K
Below Average
FTD / Avg. Volume
2.27%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Brainstorm Cell Therapeutics Inc. has
31,272
shares failed to deliver, representing 2.27%
of the average daily volume of
1,378,375
shares. Over the past year, the monthly average FTD is
79,720
shares, with the current level 61% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 1.2 | 31.27K | +97.24% |
Jun 30, 2025 | 1.12 | 15.86K | +183.38% |
May 30, 2025 | 1.12 | 5.59K | +2120.24% |
Apr 30, 2025 | 1.3 | 252 | -99.38% |
Mar 31, 2025 | 1.26 | 40.92K | +119.95% |
Feb 28, 2025 | 1.6 | 18.61K | +271.23% |
Jan 31, 2025 | 1.82 | 5.01K | -78.56% |
Dec 31, 2024 | 2.27 | 23.38K | +27.75% |
Nov 29, 2024 | 1.74 | 18.3K | +201.50% |
Oct 31, 2024 | 1.87 | 6.07K | +303400.00% |
Aug 29, 2024 | 4.78 | 2 | -100.00% |
Jul 25, 2024 | 5.49 | 115.45K | +31.35% |
Jun 27, 2024 | 5.41 | 87.89K | +8550.69% |
May 30, 2024 | 7.73 | 1.02K | -97.95% |
Apr 23, 2024 | 7.88 | 49.51K | -52.39% |
Mar 28, 2024 | 8.47 | 104K | +1459.05% |
Feb 28, 2024 | 5.5 | 6.67K | -84.20% |
Jan 31, 2024 | 5.3 | 42.23K | -97.71% |
Dec 29, 2023 | 4.1 | 1.84M | +49475.31% |
Nov 30, 2023 | 4.18 | 3.72K | -25.64% |
Oct 31, 2023 | 2.3 | 5K | -97.67% |
Sep 28, 2023 | 3.07 | 214.72K | +23652.21% |
Aug 14, 2023 | 25.05 | 904 | -72.86% |
Jul 13, 2023 | 30 | 3.33K | +514.58% |
Jun 28, 2023 | 30 | 542 | -94.11% |
May 31, 2023 | 42.75 | 9.2K | +357.56% |
Apr 28, 2023 | 43.35 | 2.01K | -68.15% |
Mar 31, 2023 | 49.5 | 6.31K | +143.35% |
Feb 28, 2023 | 33.9 | 2.59K | +79.07% |
Jan 30, 2023 | 26.18 | 1.45K | n/a |